How to buy Polynovo (PNV) shares
Learn how to easily invest in Polynovo shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Polynovo is a medical devices business based in Australia. Polynovo shares (PNV) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Polynovo has a trailing 12-month revenue of around $34.7 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Polynovo
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Polynovo. Find the share by name or ticker symbol: PNV. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Polynovo reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Polynovo. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
What's in this guide?
Polynovo stock price (ASX:PNV)Use our graph to track the performance of PNV stocks over time.
Polynovo shares at a glance
|52-week range||$0.835 - $2.82|
|50-day moving average||$1.1515|
|200-day moving average||$1.3639|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.001|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Polynovo stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Polynovo price performance over time
|1 week (2022-06-27)||-0.38%|
|1 month (2022-06-03)||10.13%|
|3 months (2022-04-04)||26.70%|
|6 months (2022-01-04)||-16.35%|
|1 year (2021-07-02)||-51.49%|
|2 years (2020-07-03)||-50.94%|
|3 years (2019-07-04)||-23.24%|
|5 years (2017-07-04)||506.98%|
Is Polynovo under- or over-valued?
Valuing Polynovo stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Polynovo's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Polynovo's P/E ratio
Polynovo's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1355x. In other words, Polynovo shares trade at around 1355x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Polynovo's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.9 million (£0.0 million).
The EBITDA is a measure of a Polynovo's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$34.7 million|
|Operating margin TTM||2.61%|
|Gross profit TTM||$24 million|
|Return on assets TTM||1.55%|
|Return on equity TTM||2.62%|
|Market capitalisation||$896.6 million|
TTM: trailing 12 months
Polynovo share dividends
We're not expecting Polynovo to pay a dividend over the next 12 months.
Have Polynovo's shares ever split?
Polynovo's shares were split on 3 May 2004. This wouldn't directly have changed the overall worth of your Polynovo shares – just the quantity. However, indirectly, the new INF% higher share price could have impacted the market appetite for Polynovo shares which in turn could have impacted Polynovo's share price.
Polynovo share price volatility
Over the last 12 months, Polynovo's shares have ranged in value from as little as $0.835 up to $2.82. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Polynovo's is 1.5196. This would suggest that Polynovo's shares are more volatile than the average for this exchange and represent, relatively speaking, a higher risk (but potentially also market-beating returns).
Polynovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing Syntrel hernia devices for hernia repair; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to Polynovo Limited in November 2014. Polynovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Stocks similar to Polynovo
Polynovo in the news
Estimating The Intrinsic Value Of PolyNovo Limited (ASX:PNV)
Frequently asked questions
More guides on Finder
How to invest in the Octava Minerals IPO
Everything we know about the Octava Minerals IPO, plus information on how to buy in.
How to invest in the Australia Sunny Glass Group IPO
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
How to buy Kincora Copper (KCC) shares
Steps to owning and managing Kincora Copper shares.
How to invest in the Dragon Mountain Gold IPO
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
Ask an Expert